(Q39384500)

English

Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Stefano A Pileri

9

object named as

Stefano A Pileri

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Claudio Agostinelli

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jennifer C Paterson

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rajeev Gupta

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Simona Righi

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Federica Sandri

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Pier P Piccaluga

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Francesco Bacci

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Elena Sabattini

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Teresa Marafioti

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

6 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

33-46

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM domain: from the cytoskeleton to the nucleus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

SCL assembles a multifactorial complex that determines glycophorin A expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Regulation of LMO2 mRNA and protein expression in erythroid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The significance of LMO2 expression in the progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Progenitor migration to the thymus and T cell lineage commitment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The thymus under siege: Lmo2 induces precancerous stem cells in a mouse model of T-ALL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2012.04198.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39384500&oldid=1824540067"